Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Liabilities (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Total Liabilities data on record, last reported at $23.4 million in Q3 2022.

  • For Q3 2022, Total Liabilities fell 91.07% year-over-year to $23.4 million; the TTM value through Sep 2022 reached $23.4 million, down 91.07%, while the annual FY2021 figure was $62.8 million, 80.11% down from the prior year.
  • Total Liabilities reached $23.4 million in Q3 2022 per AVIR's latest filing, down from $33.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $315.8 million in Q4 2020 and bottomed at $10.9 million in Q3 2020.
  • Average Total Liabilities over 3 years is $126.4 million, with a median of $62.8 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: surged 2310.34% in 2021, then plummeted 91.07% in 2022.
  • A 3-year view of Total Liabilities shows it stood at $315.8 million in 2020, then plummeted by 80.11% to $62.8 million in 2021, then plummeted by 62.77% to $23.4 million in 2022.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $23.4 million in Q3 2022, $33.9 million in Q2 2022, and $37.3 million in Q1 2022.